Yshai Yavin

6.6k total citations
20 papers, 351 citations indexed

About

Yshai Yavin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yshai Yavin has authored 20 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yshai Yavin's work include Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Yshai Yavin is often cited by papers focused on Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Yshai Yavin collaborates with scholars based in United States, United Kingdom and Australia. Yshai Yavin's co-authors include Agata Ptaszynska, Shamik Parikh, Eva Johnsson, Traci A. Mansfield, Kristina Johnsson, Hiddo J.L. Heerspink, Bruce Neal, Vlado Perkovic, Jingwei Li and Alexander T. Cohen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

Yshai Yavin

20 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yshai Yavin United States 10 262 98 98 71 69 20 351
Zhenwei Fang China 6 226 0.9× 111 1.1× 97 1.0× 32 0.5× 51 0.7× 14 328
Susanne Jung Germany 11 183 0.7× 82 0.8× 68 0.7× 48 0.7× 175 2.5× 30 364
Hiroyuki Tanaka Japan 8 133 0.5× 204 2.1× 54 0.6× 24 0.3× 117 1.7× 17 362
Aaron Y. Kluger United States 9 231 0.9× 114 1.2× 107 1.1× 42 0.6× 98 1.4× 17 364
Laura Heenan United States 4 471 1.8× 138 1.4× 165 1.7× 38 0.5× 94 1.4× 7 532
Frank Geurts Netherlands 7 246 0.9× 134 1.4× 103 1.1× 124 1.7× 56 0.8× 10 383
Hans-Ulrich Haering Germany 8 94 0.4× 75 0.8× 56 0.6× 21 0.3× 84 1.2× 19 247
Atit Dharia Canada 6 170 0.6× 78 0.8× 58 0.6× 63 0.9× 39 0.6× 11 272
Shin Kawasoe Japan 9 95 0.4× 53 0.5× 34 0.3× 81 1.1× 163 2.4× 44 319
Marina V. Karg Germany 7 309 1.2× 129 1.3× 111 1.1× 46 0.6× 145 2.1× 17 422

Countries citing papers authored by Yshai Yavin

Since Specialization
Citations

This map shows the geographic impact of Yshai Yavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yshai Yavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yshai Yavin more than expected).

Fields of papers citing papers by Yshai Yavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yshai Yavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yshai Yavin. The network helps show where Yshai Yavin may publish in the future.

Co-authorship network of co-authors of Yshai Yavin

This figure shows the co-authorship network connecting the top 25 collaborators of Yshai Yavin. A scholar is included among the top collaborators of Yshai Yavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yshai Yavin. Yshai Yavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Januzzi, James L., Yuxi Liu, Naveed Sattar, et al.. (2024). Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial. American Heart Journal. 271. 38–47. 3 indexed citations
2.
Mohebi, Reza, Yuxi Liu, Michael K. Hansen, et al.. (2023). Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points. Clinical Journal of the American Society of Nephrology. 19(4). 429–437. 5 indexed citations
3.
Ferrannini, Giulia, Carol A. Pollock, Andrea Natali, et al.. (2023). Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE. Cardiovascular Diabetology. 22(1). 100–100. 5 indexed citations
4.
Januzzi, James L., Reza Mohebi, Yuxi Liu, et al.. (2023). Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial. Circulation. 148(8). 651–660. 15 indexed citations
5.
Mohebi, Reza, Yuxi Liu, Michael K. Hansen, et al.. (2023). Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial. Cardiovascular Diabetology. 22(1). 176–176. 9 indexed citations
6.
Nadkarni, Girish N., Bruce Neal, Kenneth W. Mahaffey, et al.. (2022). A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease. Kidney360. 3(9). 1599–1602. 1 indexed citations
7.
Heerspink, Hiddo J.L., Megumi Oshima, Hong Zhang, et al.. (2021). Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial. American Journal of Kidney Diseases. 79(2). 244–256.e1. 37 indexed citations
8.
Sen, Taha, Jingwei Li, Brendon L. Neuen, et al.. (2021). Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial. Diabetologia. 64(10). 2147–2158. 50 indexed citations
9.
Sarraju, Ashish, Jingwei Li, Christopher P. Cannon, et al.. (2020). CANAGLIFLOZIN (CANA) REDUCES CARDIOVASCULAR (CV) AND RENAL EVENTS INDEPENDENT OF BASELINE HEART FAILURE (HF): A CREDENCE SECONDARY ANALYSIS. Journal of the American College of Cardiology. 75(11). 1018–1018. 5 indexed citations
10.
11.
Zhou, Zien, Brendon L. Neuen, Jie Yu, et al.. (2020). Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 23(1). 252–257. 18 indexed citations
12.
Sen, Taha, Jingwei Li, Bruce Neal, et al.. (2020). 1098-P: Biomarkers of Tubular Injury and Effects of Canagliflozin in the CANVAS Trial. Diabetes. 69(Supplement_1). 1 indexed citations
13.
Desai, Mehul, Yshai Yavin, Dainius Balis, et al.. (2017). Renal safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 19(6). 897–900. 21 indexed citations
14.
Yavin, Yshai, Traci A. Mansfield, Agata Ptaszynska, et al.. (2016). Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis. Diabetes Therapy. 7(1). 125–137. 52 indexed citations
15.
Johnsson, Kristina, Eva Johnsson, Traci A. Mansfield, et al.. (2016). Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials. Postgraduate Medicine. 128(4). 346–355. 31 indexed citations
16.
Fioretto, Paola, Traci A. Mansfield, Agata Ptaszynska, et al.. (2016). Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies. Drugs & Aging. 33(7). 511–522. 37 indexed citations
17.
Yavin, Yshai, et al.. (2009). Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence?. Thrombosis and Haemostasis. 101(3). 422–427. 8 indexed citations
18.
Yavin, Yshai & Alexander T. Cohen. (2008). Venous Thromboembolism Prophylaxis for the Medical Patient: Where Do We Stand?. Seminars in Respiratory and Critical Care Medicine. 29(1). 75–82. 7 indexed citations
19.
Yavin, Yshai, et al.. (2005). New antithrombotics in the prevention of thromboembolic disease. European Journal of Internal Medicine. 16(4). 257–266. 5 indexed citations
20.
Yavin, Yshai, et al.. (2005). Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk. American Journal of Cardiovascular Drugs. 5(6). 409–415. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenwei Fang Breakdown of academic impact, for papers by Susanne Jung Breakdown of academic impact, for papers by Hiroyuki Tanaka Breakdown of academic impact, for papers by Aaron Y. Kluger Breakdown of academic impact, for papers by Laura Heenan Breakdown of academic impact, for papers by Frank Geurts Breakdown of academic impact, for papers by Hans-Ulrich Haering Breakdown of academic impact, for papers by Atit Dharia Breakdown of academic impact, for papers by Shin Kawasoe Breakdown of academic impact, for papers by Marina V. Karg
Rankless by CCL
2026